BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Pugliese NR, Pieroni A, De Biase N, Di Fiore V, Nesti L, Agostoni P, Dini FL. Impact of diabetes on cardiopulmonary function: the added value of a combined cardiopulmonary and echocardiography stress test. Heart Fail Rev 2021. [PMID: 34820732 DOI: 10.1007/s10741-021-10194-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Harada K, Yamada S, Mamiya K, Higo S, Suzuki H, Teshima Y, Matsunaga S, Harada K, Nagao T, Shinoda N, Kato M, Marui N, Amano T, Murohara T. Cardiopulmonary exercise responses in patients with non-ischemic heart failure and a mildly reduced ejection fraction. Future Cardiol 2022;18:627-34. [PMID: 35674279 DOI: 10.2217/fca-2021-0135] [Reference Citation Analysis]
2 Hyrylä VV, Rissanen AE, Peltonen JE, Koponen AS, Tikkanen HO, Tarvainen MP. Altered Expiratory Flow Dynamics at Peak Exercise in Adult Men With Well-Controlled Type 1 Diabetes. Front Physiol 2022;13:836814. [DOI: 10.3389/fphys.2022.836814] [Reference Citation Analysis]
3 Palazzuoli A, Savarese G. An update on diabetes spectrum in heart failure: current evidence and potential therapeutic applications. Heart Fail Rev. [DOI: 10.1007/s10741-021-10202-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 De Biase N, Del Punta L, Pugliese NR. Reply: Epicardial adipose tissue: does it mediate the cardio-protective effects of SGLT-2 inhibitors in subjects with heart failure? Eur J Heart Fail 2022. [PMID: 34985799 DOI: 10.1002/ejhf.2423] [Reference Citation Analysis]